1. Catalogs
  2. MIM Software
  3. mim Symphony Bx

mim Symphony Bx

mim Symphony Bx

mim Symphony Bx

Product catalog summary
Overview: The document discusses a collaborative suite for radiology and urology, focusing on MR-guided biopsy without the need for an MR suite. It highlights the capabilities of MIM Software in enhancing prostate cancer management through advanced diagnostic tools.
Specifications: MIM provides tools for displaying and fusing multi-parametric MR images, allowing suspicious lesions to be contoured and dynamically displayed. Time activity curves are generated to highlight contrast wash-in and wash-out. The Reslicer™ tool enables reorientation of MR images to match TRUS images for biopsy preparation.
Procedures: The process involves radiologists defining MR targets, which urologists can display on live TRUS images. This point-and-shoot approach allows for precise sampling and recording of biopsy locations, focusing on areas of high suspicion.
Standards and Recommendations: The document emphasizes the use of multi-parametric MR (T2W, DCE, DWI) as the new standard in prostate imaging for cancer detection. MIM Symphony Bx facilitates collaboration between radiologists and urologists, providing tools for MR-guided biopsy teams.
Benefits: MR-guided biopsies offer higher yield and more accurate staging, benefiting patient management and treatment decisions. The integration of imaging tools aids in planning MR-targeted biopsies, transperineal mapping, brachytherapy seed implants, and cryotherapy salvage.
Testimonials: Dr. Peter Grimm from the Prostate Cancer Center of Seattle praises Symphony Bx for its capabilities in prostate cancer management.
Contact Information: MIM Software Inc. is based in Cleveland, Ohio, with additional offices in Beijing, China, and The Hague, Netherlands. Contact details and addresses are provided for each location.
See more

Catalog excerpts

mim Symphony Bx-1

A Collaborative Suite for Radiology and Urology

 Open the catalog to page 1
mim Symphony Bx-2

MR Guided Biopsy without an MR Suite he new standard in prostate imaging for cancer detection T2 + ADC with DCE curve analysis is multi-parametric MR (T2W, DCE, DWI). Until now, urologists MIM® PROVIDES advanced have not been able to effectively use this targeted information to including the ability to display guide their biopsy sampling. MIM Symphony Bx is changing this with images. Suspicious lesions can powerful but easy-to-use tools biopsy team. displayed on each MR image. the TRUS images – all before Time activity curves are It is an amazing advance in prostate cancer management automatically...

 Open the catalog to page 2
mim Symphony Bx-3

AT THE START of the procedure, the urologist is only a few clicks away from displaying the radiologistdefined MR targets on the live TRUS image. Using a point-and-shoot approach, the targets can be sampled and the precise locations of the samples recorded. With little additional time and effort in the room, biopsies can now be focused on areas of high suspicion as identified by MR. “Symphony Bx has outstanding capabilities in integrating multiple imaging tools in the diagnosis and treatment of prostate cancer. We use it to easily plan MR-targeted biopsies, design transperineal mapping, plan brachytherapy...

 Open the catalog to page 3
mim Symphony Bx-4

25800 Science Park Drive - Suite 180 Cleveland, OH 44122 866-421-2536 www.mimsoftware.com [email protected] © MIM Software Inc. 2013 All Rights Reserved MIM Software Beijing Co., Ltd. 北京明维视景医疗软件开发有限公司 地址: 北京市海淀区苏州街29号 维亚大厦605室,邮编100080 电话 86-10-82626590 邮箱 [email protected] Emergo Europe Molenstraat 15 2513 BH The Hague The Netherlands

 Open the catalog to page 4

All MIM Software catalogs and technical brochures

  1. mobile mim

    4  Pages

  2. mim neuro

    4  Pages

  3. mim Symphony

    8  Pages

  4. mim Maestro

    8  Pages

Archived catalogs

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.